Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

APREMILAST vs APREPITANT: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

APREMILAST vs APREPITANT: Safety Overview

Metric APREMILAST APREPITANT
Total FAERS Reports 136,713 5,620
Deaths Reported 4,704 1,195
Death Rate 3.4% 21.3%
Hospitalizations 9,544 2,917
Average Patient Age 54.0 yrs 52.8 yrs
% Female Patients 67.3% 70.9%
FDA Approval Date Apr 7, 2023 Dec 17, 2015
Manufacturer Amgen, Inc Heron Therapeutics, Inc.
Route ORAL INTRAVENOUS
Marketing Status Prescription Prescription